Colorectal Cancer Trial, Recruiting NCT06964438 Sponsor: University of Nottingham Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06964438
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older at the time their diagnosis was discussed by a specialist team (called a multi-disciplinary team, or MDT)
  • People diagnosed with colorectal cancer, gastric (stomach) cancer, or a non-invasive growth in the bowel or stomach — either confirmed by tissue testing or strongly suspected based on scans — where the treatment plan is curative (aimed at removing the cancer)
  • People whose agreed treatment plan includes open or keyhole (laparoscopic or robot-assisted) surgery to remove part of the bowel or stomach at Royal Derby Hospital
  • People who are mobile and well enough to take part in the standard enhanced recovery programme after surgery
  • People who can hold a basic conversation in English
  • People who are able to give informed consent to participate

Who may not be able to join:

  • People with stomach or oesophageal cancer that requires surgery involving the chest (thoracotomy or thoracoscopy)
  • People with a pre-existing condition affecting the nerves or muscles (including Parkinson's disease)
  • People who have a pacemaker, implantable heart defibrillator, or any other implanted nerve-stimulating device
  • People who have metal implants or metalwork in either upper leg, hip, knee, or thigh bone
  • People with dementia, another cognitive condition, or a language barrier that would prevent them from following instructions or operating the muscle-stimulation device used in the trial
  • People who are unable to give informed consent
  • People whose disability means they require a walking frame, wheeled frame, or wheelchair to move around, or who are bed-bound, as this would prevent completion of the standard post-surgery recovery programme
  • People with peripheral vascular disease (poor blood circulation in the limbs)
  • People with epilepsy
  • People with a pre-existing diagnosis of chronic kidney disease, or whose kidney function test result falls below a certain level at the screening visit
  • People with a pre-existing diagnosis of liver disease
  • People who require a breathing tube (intubation) or admission to intensive care during the first five days after surgery (note: surgical high dependency unit patients would still be considered)
  • People who need to return to the operating theatre for a surgical complication within the first five days after their operation
  • People with a history of rhabdomyolysis (a condition involving serious muscle breakdown)
  • People who are pregnant
  • People who have had a deep vein thrombosis (blood clot in a vein) within the past six months
  • People with an allergy to whey protein
  • People who decline whey protein products due to dietary requirements or intolerance
  • People currently participating in another clinical trial, or who have done so within the last six months
  • People with a known blood-borne virus infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00441332724687

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Nottingham
Registry
ClinicalTrials.gov
Start date
5 June 2025
Est. completion
1 February 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Post-operative vastus lateralis (VL) muscle mass loss

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov